Viridian Therapeutics Inc... (VRDN)
NASDAQ: VRDN
· Real-Time Price · USD
18.53
0.09 (0.49%)
At close: Aug 15, 2025, 3:59 PM
18.54
0.05%
After-hours: Aug 15, 2025, 05:32 PM EDT
Viridian Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 75K | 72K | 72K | 86K | 72K | 72K | 72K | 72K | 72K | 98K | 105K | 1.2M | 256K | 216K | 214K | 208K | 1.09M | 1.45M |
Cost of Revenue | n/a | n/a | n/a | n/a | 5.79M | 345K | 350K | 335K | 432K | 205K | 39.32M | 22.12M | 21.71M | 140K | 632K | 8.12M | 12.56M | 13.81M |
Gross Profit | 75K | 72K | -51K | 86K | -5.72M | -273K | -278K | -263K | -360K | -107K | -39.21M | -20.92M | -21.46M | 76K | -418K | -7.91M | -11.47M | -12.36M |
Operating Income | -106.77M | -93.87M | -87.47M | -83.48M | -72.19M | -55.9M | -71.48M | -51.22M | -59.27M | -72.47M | -49.07M | -29.79M | -29.56M | -25.89M | -29.08M | -14.13M | -18M | -18.52M |
Interest Income | 6.55M | 7.54M | 8.61M | 7.79M | 7.79M | 7.94M | 5.53M | 4.16M | 4.38M | 4.49M | 3.45M | 1.04M | 227K | 196K | 138K | 91K | 34K | 55K |
Pretax Income | -100.73M | -86.91M | -79.72M | -76.69M | -64.99M | -48.54M | -66.86M | -47.66M | -55.06M | -68.15M | -45.78M | -28.91M | -29.49M | -25.69M | -28.95M | -14.04M | -17.96M | -18.46M |
Net Income | -100.73M | -86.91M | -79.72M | -76.69M | -64.99M | -48.54M | -66.86M | -47.66M | -55.06M | -68.05M | -42.5M | -28.02M | -29.49M | -25.5M | -28.95M | -14.04M | -17.96M | -18.46M |
Selling & General & Admin | 20.22M | 17.1M | 15.58M | 14.41M | 16.07M | 15.03M | 32.99M | 20.91M | 19.26M | 21.83M | 9.85M | 8.86M | 8.11M | 8.36M | 6.9M | 6.22M | 6.52M | 6.16M |
Research & Development | 86.63M | 76.83M | 71.96M | 69.16M | 56.19M | 40.94M | 38.56M | 30.39M | 40.08M | 50.74M | 39.32M | 22.12M | 21.71M | 17.75M | 22.39M | 8.12M | 12.56M | 13.81M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 106.84M | 93.94M | 87.54M | 83.57M | 72.26M | 55.97M | 71.55M | 51.3M | 59.35M | 72.57M | 49.17M | 30.98M | 29.82M | 26.11M | 29.3M | 14.34M | 19.09M | 19.97M |
Interest Expense | 514K | 586K | 858K | 1M | 597K | 587K | 916K | 600K | 166K | 165K | 168K | 164K | 154K | n/a | 3K | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 106.84M | 93.94M | 87.54M | 83.57M | 72.26M | 55.97M | 71.55M | 51.3M | 59.35M | 72.57M | 49.17M | 30.98M | 29.82M | 26.11M | 29.3M | 14.34M | 19.09M | 19.97M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | -145K | n/a | -135K | n/a | -105K | -3.28M | -880K | 227K | -196K | 3K | 91K | 9K | 55K |
Shares Outstanding (Basic) | 81.59M | 81.34M | 80.05M | 66.42M | 63.85M | 61.1M | 49.68M | 43.65M | 43.25M | 42.24M | 40.54M | 33.74M | 27.76M | 26.13M | 11.18M | 11.18M | 8.11M | 6.34M |
Shares Outstanding (Diluted) | 81.59M | 81.34M | 80.05M | 66.42M | 63.85M | 61.1M | 49.68M | 43.65M | 43.25M | 42.24M | 40.54M | 33.74M | 27.76M | 26.13M | 11.18M | 11.18M | 8.11M | 6.34M |
EPS (Basic) | -1 | -0.87 | -0.81 | -1.15 | -1.02 | -0.79 | -1.35 | -1.09 | -1.27 | -1.61 | -1.05 | -0.83 | -1.06 | -0.98 | -2.59 | -1.26 | -2.22 | -2.91 |
EPS (Diluted) | -1 | -0.87 | -0.81 | -1.15 | -1.02 | -0.79 | -1.35 | -1.09 | -1.27 | -1.61 | -1.05 | -0.83 | -1.06 | -0.98 | -2.59 | -1.26 | -2.22 | -2.91 |
EBITDA | -100.11M | -86.21M | -78.74M | -75.56M | -63.85M | -47.61M | -65.59M | -46.73M | -54.47M | -67.78M | -45.42M | -28.74M | -29.18M | -25.55M | -28.31M | -13.91M | -17.84M | -18.48M |
EBIT | -100.22M | -86.33M | -78.87M | -75.69M | -64.4M | -47.95M | -65.94M | -47.06M | -54.9M | -67.99M | -45.62M | -28.74M | -29.34M | -25.69M | -28.94M | -14.04M | -17.96M | -18.52M |
Depreciation & Amortization | 113K | 117K | 123K | 130K | 142K | 345K | 350K | 335K | 432K | 205K | 196K | 62K | 157K | 140K | 632K | 130K | 125K | 133K |